这是一篇来自已证抗体库的有关人类 IDH2的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IDH2 抗体。
IDH2 同义词: D2HGA2; ICD-M; IDH; IDHM; IDP; IDPM; mNADP-IDH; isocitrate dehydrogenase [NADP], mitochondrial; NADP(+)-specific ICDH; isocitrate dehydrogenase 2 (NADP+), mitochondrial; oxalosuccinate decarboxylase

艾博抗(上海)贸易有限公司
兔 单克隆(EPR7577)
  • 免疫印迹; 人类; 图 5g
艾博抗(上海)贸易有限公司 IDH2抗体(Abcam, ab131263)被用于被用于免疫印迹在人类样品上 (图 5g). Cell Stem Cell (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:50; 图 st1
艾博抗(上海)贸易有限公司 IDH2抗体(abcam, ab55271)被用于被用于免疫印迹在人类样品上浓度为1:50 (图 st1). Nat Commun (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 3
艾博抗(上海)贸易有限公司 IDH2抗体(Abcam, ab55271)被用于被用于免疫印迹在人类样品上 (图 3). Nature (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 表 1
艾博抗(上海)贸易有限公司 IDH2抗体(Abcam, Ab55271)被用于被用于免疫印迹在人类样品上 (表 1). elife (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 表 1
艾博抗(上海)贸易有限公司 IDH2抗体(Abcam, ab55271)被用于被用于免疫印迹在人类样品上 (表 1). elife (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司 IDH2抗体(Abcam, ab55271)被用于被用于免疫印迹在人类样品上浓度为1:1000. Nat Commun (2015) ncbi
Novus Biologicals
兔 多克隆
  • 免疫细胞化学; 人类; 1:100; 图 s4
Novus Biologicals IDH2抗体(Novus Biologicals, NBP2-22166)被用于被用于免疫细胞化学在人类样品上浓度为1:100 (图 s4). Nature (2014) ncbi
西格玛奥德里奇
小鼠 单克隆(5F11)
  • 免疫印迹; 人类; 图 2a
西格玛奥德里奇 IDH2抗体(Sigma, 5F11)被用于被用于免疫印迹在人类样品上 (图 2a). Sci Rep (2017) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 0.3 ug/ml; 图 s2d
西格玛奥德里奇 IDH2抗体(Sigma, SAB2501533)被用于被用于免疫印迹在人类样品上浓度为0.3 ug/ml (图 s2d). Cell Death Dis (2015) ncbi
文章列表
  1. Li X, Tan J, Xiao Z, Zhao Y, Han S, Liu D, et al. Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury. Sci Rep. 2017;7:43559 pubmed 出版商
  2. Zhu Z, Li C, Zeng Y, Ding J, Qu Z, Gu J, et al. PHB Associates with the HIRA Complex to Control an Epigenetic-Metabolic Circuit in Human ESCs. Cell Stem Cell. 2017;20:274-289.e7 pubmed 出版商
  3. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  4. Jiang L, Shestov A, Swain P, Yang C, Parker S, Wang Q, et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature. 2016;532:255-8 pubmed 出版商
  5. Richarson A, Scott D, Zagnitko O, Aza Blanc P, Chang C, Russler Germain D. Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation. elife. 2016;5:e10860 pubmed 出版商
  6. Fiehn O, Showalter M, Schaner Tooley C. Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. elife. 2016;5: pubmed 出版商
  7. Carpentieri A, Cozzoli E, Scimeca M, Bonanno E, Sardanelli A, Gambacurta A. Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor. Cell Death Dis. 2015;6:e1974 pubmed 出版商
  8. Lin A, Abbas S, Kim S, Ortega M, Bouamar H, Escobedo Y, et al. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nat Commun. 2015;6:7768 pubmed 出版商
  9. Saha S, Parachoniak C, Ghanta K, Fitamant J, Ross K, Najem M, et al. Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. Nature. 2014;513:110-4 pubmed 出版商